| Sample | Title | Value | Rank |
|---|
| GSM16943 | Wild Type Control Set A | 740.6 | 93 |
| GSM18491 | WT Control Sample B | 979.8 | 95 |
| GSM18492 | MDA-MB-231 Breast Cancer Cells Stably Expressing wild-type ERa 1 Hr Treatment Sample A | 437.1 | 89 |
| GSM18493 | MDA-MB-231 Breast Cancer Cells Stably Expressing wild-type ERa 1 Hr Treatment Sample B | 930.8 | 95 |
| GSM18494 | MDA-MB-231 Breast Cancer Cells Stably Expressing wild-type ERa 2 Hr Treatment Sample A | 598.5 | 92 |
| GSM18495 | MDA-MB-231 Breast Cancer Cells Stably Expressing wild-type ERa 2 Hr Treatment Sample B | 721.3 | 93 |
| GSM18496 | MDA-MB-231 Breast Cancer Cells Stably Expressing Mutant ERa LQ Control Sample A | 630.2 | 92 |
| GSM18497 | MDA-MB-231 Breast Cancer Cells Stably Expressing mutant ERa LQ Sample B | 1269.5 | 97 |
| GSM18498 | MDA-MB-231 Breast Cancer Cells Stably Expressing mutant ERa LQ 1 Hr Treatment of 10 nM E2 Sample A | 683.8 | 93 |
| GSM18499 | MDA-MB-231 Breast Cancer Cells Stably Expressing mutant ERa LQ 1 Hr Treatment of 10 nM E2 Sample B | 843.9 | 94 |
| GSM18500 | MDA-MB-231 Breast Cancer Cells Stably Expressing mutant ERa LQ 2 Hr Treatment of 10 nM E2 Sample A | 691.7 | 93 |
| GSM18501 | MDA-MB-231 Breast Cancer Cells Stably Expressing mutant ERa LQ 2 Hr Treatment of 10 nM E2 Sample B | 1095.6 | 96 |